Search results
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 hours agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 4 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Dai ichi Life Insurance Company Ltd
ETF DAILY NEWS· 7 hours agoDai ichi Life Insurance Company Ltd lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 47.1% during the fourth quarter, according to its most recent ...
...INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with...
WJTV Jackson· 14 hours agoAttorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen ...
Biogen shares maintain overweight rating By Investing.com
Investing.com· 2 days agoOn Wednesday, Morgan Stanley (NYSE:MS) maintained its positive stance on Biogen (NASDAQ:BIIB), the...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 1 day agoBiogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
Needham & Company LLC Reiterates “Buy” Rating for Biogen (NASDAQ:BIIB)
ETF DAILY NEWS· 14 hours agoBiogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report issued on Wednesday, Benzinga reports. Needham & Company ...
Biogen maintains stock target with Buy rating on acquisition intention By Investing.com
Investing.com· 2 days agoOn Wednesday, Biogen Inc (NASDAQ:BIIB) received confirmation from Stifel that its Buy rating and...
Biogen buys California biotech for $1.15 billion - The Boston Globe
The Boston Globe· 2 days agoBiogen said Wednesday it will acquire a California biotech that specializes in diseases of the...
Biogen enters deal to acquire HI-Bio for $1.8bn
Pharmaceutical Technology via Yahoo Finance· 1 day agoBiogen has signed a definitive agreement to acquire clinical-stage biotechnology company Human Immunology Biosciences (HI-Bio) in a $1.8bn deal. The...
